A new injection for advanced Parkinson's disease
Part of Brain & nervous system clinical trials.
This trial tests an experimental injection (UX-DA003) that may help people with advanced Parkinson’s disease whose current medications are losing effect. The goal is to see if it improves movement and reduces daily 'off' time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 75 years old.
- You have had Parkinson’s disease for 5 to 20 years.
- You have a good response to levodopa, but your symptoms return for more than 2 hours a day (as shown by a test).
- Your Parkinson’s medications have been the same for at least 4 weeks.
- You are generally healthy and do not have other serious medical conditions or infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an injection that may help reduce Parkinson's symptoms when they fluctuate, such as when medication wears off. It is for people who are already taking levodopa but still have periods of poor symptom control.
This trial tests an experimental drug called RO7568282 to see if it is safe and can help with early Parkinson's disease symptoms. It is for people who have been taking a stable dose of levodopa alone for at least two months.
This study tests a new form of Parkinson's medication given through a pump to see how well it works in everyday life for people in the early stages of advanced Parkinson's. It may help control symptoms and improve daily function.
This trial tests an investigational drug called IPS101A in people with advanced Parkinson's disease. It aims to see if the drug is safe and how well it works when standard treatments are no longer enough.
This trial tests a new treatment called DSP-1083 for people with Parkinson's disease whose symptoms are not well controlled with standard medications. The study will check if it is safe and if it helps improve movement and daily function.
This trial tests a new treatment called XS411 for people with early-onset Parkinson's disease (age 50 or younger at diagnosis). It is for those whose motor symptoms are not well controlled with standard medications and who may benefit from a neurosurgical procedure.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.